retatrutide trial produces up to 30.3% weight loss in Phase 3 Retatrutide for weight loss: Study

Other major players, which include AstraZeneca, Pfizer, Sanofi, Roche, Amgen, and Boehringer Ingelheim, are expanding pipelines via innovation, acquisitions, and partnerships

We advise researchers who are interested in studying BPC-157 to visit our #1 recommended vendor of research chemicals.

When it becomes available, it is expected to come in an easy-to-use pre-filled pen

Get unlimited visits with your care team 24/7 provider support is built into your membership, so your health plan can adjust as you go

You can benefit from retatrutide therapy if: You are obese (BMI 30 kg/m or more) or overweight (BMI 27 kg/m or more) with at least one weight-related health condition

Track your food intake